1 / 24

Global Next Generation Oncology Devices and Solutions Market

The global next-generation oncology devices and solutions market report highlights that the market was valued at $3,268.2 million in 2021 and is expected to reach $5,971.3 million by the end of 2031. The market is expected to grow at a CAGR of 6.41% during the forecast period from 2022 to 2031.

bisreports
Download Presentation

Global Next Generation Oncology Devices and Solutions Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. sres Next-Generation Oncology Devices and Solutions Market- A Global and Regional Analysis Table of Content Next-Generation Oncology Devices and Solutions Market Attribution: https://pixabay.com/photos/tire-rim-car-mechanic-114259/ Focus on Clinical Application, End User, Type, and Region Analysis and Forecast: 2022-2031 June 2022 1 All rights reserved at BIS Research Inc.

  2. BIS Research is a leading market intelligence and technology research company. BIS Research publishes in- depth market intelligence reports focusing on the market estimations, technology analysis, emerging high- growth applications, deeply segmented granular country-level market data and other important market parameters useful in the strategic decision making for senior management. BIS Research provides multi-client reports, company profiles, databases, and custom research services. Next-Generation Oncology Devices and Solutions Market Copyright © 2022 BIS Research Inc. All Rights Reserved. This document contains highly confidential information and is the sole property of BIS Research. Disclosing, copying, circulating, quoting or otherwise reproducing any or all contents of this document is strictly prohibited. Access to this information is provided exclusively for the benefit of the people or organization concerned. It may not be accessed by or offered whether for sale or otherwise to any third party. 2 All rights reserved at BIS Research Inc.

  3. Table of Content Executive Summary .......................................................................... 23 Scope of the Study ........................................................................... 27 Research Methodology ..................................................................... 29 1.Markets ..................................................................................... 35 1.1 Global Market Outlook .................................................................................... 36 1.1.1Product Definition ....................................................................................... 36 1.1.2Inclusion and Exclusion Criteria ................................................................ 36 1.1.3Key Findings ................................................................................................ 36 1.1.4Assumptions and Limitations .................................................................... 37 1.1.5Global Market Scenario ............................................................................... 38 1.1.5.1 Realistic Growth Scenario ................................................................................. 38 1.1.5.2 Optimistic Growth Scenario ............................................................................... 39 1.1.5.3 Pessimistic/Conservative Growth Scenario ....................................................... 40 1.2 Industry Outlook .............................................................................................. 40 1.2.1Key Trends ................................................................................................... 40 Next-Generation Oncology Devices and Solutions Market 1.2.1.1 Emerging Use of Wearables .............................................................................. 40 1.2.1.2 Growing Demand for Point-of-Care Testing (POCT) in Oncology ..................... 41 1.2.1.3 Growing Popularity of Smartphone-Based Diagnostics ..................................... 41 1.2.1.4 Growing Demand for Minimally Invasive Methods of Cancer Diagnosis ........... 41 1.2.1.5 Rising Number of Partnerships and Regulatory Milestones .............................. 42 1.2.2Opportunity Assessment ............................................................................ 42 1.2.2.1 Short-Term Potential .......................................................................................... 42 1.2.2.2 Long-Term Potential .......................................................................................... 43 1.2.3Patent Analysis ............................................................................................ 44 1.2.3.1 Awaited Technological Developments ............................................................... 44 1.2.3.2 Patent Filing Trend (by Country) ........................................................................ 44 3 All rights reserved at BIS Research Inc.

  4. 1.2.3.3 Patent Filing Trend (by Year) ............................................................................. 45 1.2.4Product Benchmarking ............................................................................... 45 1.2.5End-User Perceptions ................................................................................. 48 1.2.6Case Studies ................................................................................................ 48 1.2.6.1 Stereotactic Body Radiation Therapy (SBRT) using TrueBeam for Inoperable Early-Stage Non-Small Cell Lung Cancer (NSCLC) ........................ 48 1.2.6.2 Breast Cancer Treatment Using Halcyon .......................................................... 49 1.3 Impact of COVID-19 on the Next-Generation Oncology Devices and Solutions Market .............................................................................................. 49 1.3.1Impact on Adoption of Oncology Solutions .............................................. 49 1.3.2Impact on Market Size ................................................................................. 50 1.3.2.1 Pre-COVID-19 Phase ........................................................................................ 50 1.3.2.2 During COVID-19 Phase ................................................................................... 50 1.3.2.3 Post-COVID-19 Phase ....................................................................................... 50 1.3.3Market Entry Barriers and Opportunities .................................................. 51 1.4 Business Dynamics ......................................................................................... 51 1.4.1Impact Analysis ........................................................................................... 51 1.4.2Business Drivers ......................................................................................... 52 Next-Generation Oncology Devices and Solutions Market 1.4.2.1 Increasing Prevalence of Oncology and a Growing Geriatric Population .......... 52 1.4.2.2 Increase in Demand for Software Solutions in Oncology .................................. 53 1.4.2.3 Emerging Technologies in Oncology Testing and Treatment ............................ 53 1.4.2.4 Rising Preference for Minimally Invasive Techniques of Diagnosis and Treatment .......................................................................................................... 54 1.4.3Business Restraints .................................................................................... 54 1.4.3.1 Side Effects and Risks Associated with Cancer Treatment ............................... 54 1.4.3.2 Dearth of Well-Trained and Skilled Professionals in Oncology ......................... 55 1.4.4Business Opportunities .............................................................................. 55 1.4.4.1 Increasing Demand for Home-Based Cancer Testing ....................................... 55 1.4.4.2 Growing Demand for Targeted Therapy ............................................................ 56 4 All rights reserved at BIS Research Inc.

  5. 2.Global Next-Generation Oncology Devices and Solutions Market, (by Clinical Application) ................................................ 57 2.1 Opportunity Assessment ................................................................................ 58 2.2 Growth-Share Matrix ....................................................................................... 59 2.3 Lung Cancer ..................................................................................................... 59 2.4 Prostate Cancer ............................................................................................... 60 2.5 Breast Cancer .................................................................................................. 61 2.6 Others ............................................................................................................... 62 3.Global Next-Generation Oncology Devices and Solutions Market (by End User) ................................................................. 64 3.1 Opportunity Assessment ................................................................................ 65 3.2 Growth-Share Matrix ....................................................................................... 66 3.3 Hospitals........................................................................................................... 66 3.4 Diagnostic Imaging Centers ........................................................................... 67 3.5 Others (Ambulatory Surgical Centers, Cancer Care Centers, and Government Institutions) ................................................................................ 68 4.Global Next-Generation Oncology Devices and Solutions Next-Generation Oncology Devices and Solutions Market Market (by Type) ........................................................................ 70 4.1 Opportunity Assessment ................................................................................ 71 4.2 Growth-Share Matrix ....................................................................................... 72 4.3 Devices ............................................................................................................. 73 4.3.1By Technology ............................................................................................. 73 4.3.1.1 High-Intensity Focused Ultrasound .................................................................... 73 4.3.1.2 Advanced Forms of Radiation Therapy ............................................................. 75 4.3.1.3 Others ................................................................................................................ 77 4.3.2By Application ............................................................................................. 78 4.3.2.1 Diagnosis ........................................................................................................... 78 5 All rights reserved at BIS Research Inc.

  6. 4.3.2.2 Treatment and Monitoring .................................................................................. 79 4.4 Software ........................................................................................................... 82 4.4.1By Application ............................................................................................. 82 4.4.1.1 Diagnosis ........................................................................................................... 82 4.4.1.2 Treatment and Monitoring .................................................................................. 83 5.Region ....................................................................................... 86 5.1 North America Next-Generation Oncology Devices and Solutions Market ............................................................................................................... 88 5.1.1Key Findings and Opportunity Assessment ............................................. 88 5.1.2Regulatory Framework ................................................................................ 89 5.1.3Key Players in North America .................................................................... 90 5.1.4Market Dynamics ......................................................................................... 91 5.1.4.1 Impact Analysis .................................................................................................. 92 5.1.5Sizing and Forecast Analysis ..................................................................... 93 5.1.5.1 North America Next-Generation Oncology Devices and Solutions Market (by Clinical Application) ..................................................................................... 93 5.1.5.2 North America Next-Generation Oncology Devices and Solutions Market (by End User) ..................................................................................................... 94 Next-Generation Oncology Devices and Solutions Market 5.1.5.3 North America Next-Generation Oncology Devices and Solutions Market (by Type) ............................................................................................................ 94 5.1.5.3.1North America Next-Generation Oncology Devices and Solutions Market, Devices (by Technology) ......................................................................................... 95 5.1.5.3.2North America Next-Generation Oncology Devices and Solutions Market, Device (by Application) ........................................................................................... 95 5.1.5.3.3North America Next-Generation Oncology Devices and Solutions Market, Software (by Application) ........................................................................................ 96 5.1.5.4 North America Next-Generation Oncology Devices and Solutions Market (by Country) ....................................................................................................... 97 5.1.5.4.1U.S. .......................................................................................................................... 97 5.1.5.4.1.1Market Dynamics .............................................................................................. 97 6 All rights reserved at BIS Research Inc.

  7. 5.1.5.4.1.2Sizing and Forecast Analysis ........................................................................... 98 5.1.5.4.1.3U.S. Next-Generation Oncology Devices and Solutions Market (by Clinical Application) ................................................................................................. 99 5.1.5.4.1.4U.S. Next-Generation Oncology Devices and Solutions Market (by End User) ........................................................................................................................ 99 5.1.5.4.2Canada ................................................................................................................... 100 5.1.5.4.2.1Market Dynamics ............................................................................................ 100 5.1.5.4.2.2Sizing and Forecast Analysis ......................................................................... 101 5.1.5.4.2.3Canada Next-Generation Oncology Devices and Solutions Market (by Clinical Application) ............................................................................................... 101 5.1.5.4.2.4Canada Next-Generation Oncology Devices and Solutions Market (by End User) .............................................................................................................. 102 5.2 Europe Next-Generation Oncology Devices and Solutions Market .......... 103 5.2.1Key Findings and Opportunity Assessment ........................................... 103 5.2.2Regulatory Framework .............................................................................. 103 5.2.3Key Players in Europe ............................................................................... 104 5.2.4Market Dynamics ....................................................................................... 106 5.2.4.1 Impact Analysis ................................................................................................ 107 5.2.5Sizing and Forecast Analysis ................................................................... 107 Next-Generation Oncology Devices and Solutions Market 5.2.5.1 Europe Next-Generation Oncology Devices and Solutions Market (by Clinical Application) ......................................................................................... 108 5.2.5.2 Europe Next-Generation Oncology Devices and Solutions Market (by End User) ................................................................................................................ 108 5.2.5.3 Europe Next-Generation Oncology Devices and Solutions Market (by Type) ................................................................................................................ 109 5.2.5.3.1Europe Next-Generation Oncology Devices and Solutions Market, Devices (by Technology) ..................................................................................................... 109 5.2.5.3.2Europe Next-Generation Oncology Devices and Solutions Market, Device (by Application) ............................................................................................................ 110 5.2.5.3.3Europe Next-Generation Oncology Devices and Solutions Market, Software (by Application) ...................................................................................................... 111 7 All rights reserved at BIS Research Inc.

  8. 5.2.5.4 Europe Next-Generation Oncology Devices and Solutions Market (by Country) ........................................................................................................... 111 5.2.5.4.1Germany ................................................................................................................ 112 5.2.5.4.1.1Market Dynamics ............................................................................................ 112 5.2.5.4.1.2Sizing and Forecast Analysis ......................................................................... 112 5.2.5.4.1.2.1Germany Next-Generation Oncology Devices and Solutions Market (by Clinical Application) .................................................................................................... 113 5.2.5.4.1.2.2Germany Next-Generation Oncology Devices and Solutions Market (by End User) ........................................................................................................................... 113 5.2.5.4.2U.K. ........................................................................................................................ 114 5.2.5.4.2.1Market Dynamics ............................................................................................ 114 5.2.5.4.2.2Sizing and Forecast Analysis ......................................................................... 114 5.2.5.4.2.2.1U.K. Next-Generation Oncology Devices and Solutions Market (by Clinical Application) ................................................................................................................. 115 5.2.5.4.2.2.2U.K. Next-Generation Oncology Devices and Solutions Market (by End User) ........................................................................................................................... 115 5.2.5.4.3France .................................................................................................................... 116 5.2.5.4.3.1Market Dynamics ............................................................................................ 116 5.2.5.4.3.2Sizing and Forecast Analysis ......................................................................... 117 5.2.5.4.3.2.1France Next-Generation Oncology Devices and Solutions Market (by Clinical Application) ................................................................................................................. 117 5.2.5.4.3.2.2France Next-Generation Oncology Devices and Solutions Market (by End User) ........................................................................................................................... 118 Next-Generation Oncology Devices and Solutions Market 5.2.5.4.4Italy ......................................................................................................................... 118 5.2.5.4.4.1Market Dynamics ............................................................................................ 118 5.2.5.4.4.2Sizing and Forecast Analysis ......................................................................... 119 5.2.5.4.4.2.1Italy Next-Generation Oncology Devices and Solutions Market (by Clinical Application) ................................................................................................................. 119 5.2.5.4.4.2.2Italy Next-Generation Oncology Devices and Solutions Market (by End User) ........................................................................................................................... 120 5.2.5.4.5Spain ...................................................................................................................... 120 5.2.5.4.5.1Market Dynamics ............................................................................................ 120 5.2.5.4.5.2Sizing and Forecast Analysis ......................................................................... 121 5.2.5.4.5.2.1Spain Next-Generation Oncology Devices and Solutions Market (by Clinical Application) ................................................................................................................. 121 8 All rights reserved at BIS Research Inc.

  9. 5.2.5.4.5.2.2Spain Next-Generation Oncology Devices and Solutions Market (by End User) ........................................................................................................................... 122 5.2.5.4.6Rest-of-Europe ....................................................................................................... 122 5.2.5.4.6.1Market Dynamics ............................................................................................ 122 5.2.5.4.6.2Sizing and Forecast Analysis ......................................................................... 123 5.2.5.4.6.2.1Rest-of-Europe Next-Generation Oncology Devices and Solutions Market (by Clinical Application) .................................................................................................... 123 5.2.5.4.6.2.2Rest-of-Europe Next-Generation Oncology Devices and Solutions Market (by End User) ................................................................................................................... 124 5.3 Asia-Pacific Next-Generation Oncology Devices and Solutions Market ............................................................................................................. 125 5.3.1Key Findings and Opportunity Assessment ........................................... 125 5.3.2Regulatory Framework .............................................................................. 125 5.3.3Key Players in Asia-Pacific ....................................................................... 126 5.3.4Market Dynamics ....................................................................................... 127 5.3.4.1 Impact Analysis ................................................................................................ 129 5.3.5Sizing and Forecast Analysis ................................................................... 130 5.3.5.1 Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by Clinical Application) ......................................................................................... 130 5.3.5.2 Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by Next-Generation Oncology Devices and Solutions Market End User) ......................................................................................................... 131 5.3.5.3 Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by Type) ................................................................................................................ 131 5.3.5.3.1Asia-Pacific Next-Generation Oncology Devices and Solutions Market, Devices (by Technology) ....................................................................................... 132 5.3.5.3.2Asia-Pacific Next-Generation Oncology Devices and Solutions Market, Device (by Application) ......................................................................................... 133 5.3.5.3.3Asia-Pacific Next-Generation Oncology Devices and Solutions Market, Software (by Application) ...................................................................................... 133 5.3.5.4 Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by Country) ........................................................................................................... 134 5.3.5.4.1Japan ..................................................................................................................... 134 9 All rights reserved at BIS Research Inc.

  10. 5.3.5.4.1.1Market Dynamics ............................................................................................ 134 5.3.5.4.1.2Sizing and Forecast Analysis ......................................................................... 135 5.3.5.4.1.2.1Japan Next-Generation Oncology Devices and Solutions Market (by Clinical Application) ................................................................................................................. 136 5.3.5.4.1.2.2Japan Next-Generation Oncology Devices and Solutions Market (by End User) ........................................................................................................................... 136 5.3.5.4.2China ...................................................................................................................... 137 5.3.5.4.2.1Market Dynamics ............................................................................................ 137 5.3.5.4.2.2Sizing and Forecast Analysis ......................................................................... 137 5.3.5.4.2.2.1China Next-Generation Oncology Devices and Solutions Market (by Clinical Application) ................................................................................................................. 138 5.3.5.4.2.2.2China Next-Generation Oncology Devices and Solutions Market (by End User) ........................................................................................................................... 138 5.3.5.4.3Australia ................................................................................................................. 139 5.3.5.4.3.1Market Dynamics ............................................................................................ 139 5.3.5.4.3.2Sizing and Forecast Analysis ......................................................................... 139 5.3.5.4.3.2.1Australia Next-Generation Oncology Devices and Solutions Market (by Clinical Application) .................................................................................................... 140 5.3.5.4.3.2.2Australia Next-Generation Oncology Devices and Solutions Market (by End User) ........................................................................................................................... 140 5.3.5.4.4India ....................................................................................................................... 141 5.3.5.4.4.1Market Dynamics ............................................................................................ 141 Next-Generation Oncology Devices and Solutions Market 5.3.5.4.4.2Sizing and Forecast Analysis ......................................................................... 141 5.3.5.4.4.2.1India Next-Generation Oncology Devices and Solutions Market (by Clinical Application) ................................................................................................................. 142 5.3.5.4.4.2.2India Next-Generation Oncology Devices and Solutions Market (by End User) ........................................................................................................................... 142 5.3.5.4.5South Korea ........................................................................................................... 143 5.3.5.4.5.1Market Dynamics ............................................................................................ 143 5.3.5.4.5.2Sizing and Forecast Analysis ......................................................................... 143 5.3.5.4.5.2.1South Korea Next-Generation Oncology Devices and Solutions Market (by Clinical Application) .................................................................................................... 144 5.3.5.4.5.2.2South Korea Next-Generation Oncology Devices and Solutions Market (by End User) ................................................................................................................... 144 5.3.5.4.6Rest-of-Asia-Pacific ............................................................................................... 145 10 All rights reserved at BIS Research Inc.

  11. 5.3.5.4.6.1Market Dynamics ............................................................................................ 145 5.3.5.4.6.2Sizing and Forecast Analysis ......................................................................... 145 5.3.5.4.6.2.1Rest-of-Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by Clinical Application) .................................................................................. 146 5.3.5.4.6.2.2Rest-of-Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by End User) .................................................................................................. 147 5.4 Rest-of-the-World Next-Generation Oncology Devices and Solutions Market ............................................................................................................. 148 5.4.1Key Findings and Opportunity Assessment ........................................... 148 5.4.2Regulatory Framework .............................................................................. 148 5.4.3Key Players in Rest-of-the-World ............................................................. 149 5.4.4Market Dynamics ....................................................................................... 150 5.4.4.1 Impact Analysis ................................................................................................ 151 5.4.5Sizing and Forecast Analysis ................................................................... 151 5.4.5.1 Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by Clinical Application) ....................................................................... 152 5.4.5.2 Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by End User) ....................................................................................... 152 5.4.5.3 Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by Type) .............................................................................................. 153 Next-Generation Oncology Devices and Solutions Market 5.4.5.3.1Rest-of-the-World Next-Generation Oncology Devices and Solutions Market, Devices (by Technology) ....................................................................................... 153 5.4.5.3.2Rest-of-the-World Next-Generation Oncology Devices and Solutions Market, Device (by Application) ......................................................................................... 154 5.4.5.3.3Rest-of-the-World Next-Generation Oncology Devices and Solutions Market, Software (by Application) ...................................................................................... 155 5.4.5.4 Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by Country) ......................................................................................... 155 5.4.5.4.1Kingdom of Saudi Arabia (K.S.A.).......................................................................... 156 5.4.5.4.1.1Market Dynamics ............................................................................................ 156 5.4.5.4.1.2Sizing and Forecast Analysis ......................................................................... 157 11 All rights reserved at BIS Research Inc.

  12. 5.4.5.4.1.2.1K.S.A. Next-Generation Oncology Devices and Solutions Market (by Clinical Application) ................................................................................................................. 157 5.4.5.4.1.2.2K.S.A. Next-Generation Oncology Devices and Solutions Market (by End User) ........................................................................................................................... 158 5.4.5.4.2Brazil ...................................................................................................................... 158 5.4.5.4.2.1Market Dynamics ............................................................................................ 158 5.4.5.4.2.2Sizing and Forecast Analysis ......................................................................... 159 5.4.5.4.2.2.1Brazil Next-Generation Oncology Devices and Solutions Market (by Clinical Application) ................................................................................................................. 159 5.4.5.4.2.2.2Brazil Next-Generation Oncology Devices and Solutions Market (by End User) ........................................................................................................................... 160 5.4.5.4.3U.A.E. ..................................................................................................................... 160 5.4.5.4.3.1Market Dynamics ............................................................................................ 160 5.4.5.4.3.2Sizing and Forecast Analysis ......................................................................... 161 5.4.5.4.3.2.1U.A.E. Next-Generation Oncology Devices and Solutions Market (by Clinical Application) ................................................................................................................. 161 5.4.5.4.3.2.2U.A.E. Next-Generation Oncology Devices and Solutions Market (by End User) ........................................................................................................................... 162 5.4.5.4.4Mexico .................................................................................................................... 162 5.4.5.4.4.1Market Dynamics ............................................................................................ 162 5.4.5.4.4.2Sizing and Forecast Analysis ......................................................................... 163 5.4.5.4.4.2.1Mexico Next-Generation Oncology Devices and Solutions Market (by Clinical Application) ................................................................................................................. 163 Next-Generation Oncology Devices and Solutions Market 5.4.5.4.4.2.2Mexico Next-Generation Oncology Devices and Solutions Market (by End User) ........................................................................................................................... 164 5.4.5.4.5Rest-of-Rest-of-the-World ...................................................................................... 164 5.4.5.4.5.1Market Dynamics ............................................................................................ 164 5.4.5.4.5.2Sizing and Forecast Analysis ......................................................................... 165 5.4.5.4.5.2.1Rest-of-Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by Clinical Application) .................................................................................. 165 5.4.5.4.5.2.2Rest-of-Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by End User) .................................................................................................. 166 6. Markets - Competitive Benchmarking ...................................... 167 6.1 Competitive Landscape ................................................................................ 168 12 All rights reserved at BIS Research Inc.

  13. 6.1.1Key Strategies and Developments ........................................................... 168 6.1.1.1 Regulatory and Legal Activities ....................................................................... 169 6.1.1.2 Partnerships, Alliances, and Business Expansions ......................................... 170 6.1.1.3 New Offerings .................................................................................................. 171 6.1.1.4 Mergers and Acquisitions ................................................................................ 171 6.1.1.5 Funding Activities ............................................................................................. 172 6.2 Market Share Analysis .................................................................................. 173 Next-Generation Oncology Devices and Solutions Market 13 All rights reserved at BIS Research Inc.

  14. List of Figures Figure 1:Global Next-Generation Oncology Devices and Solutions Market, Impact Analysis Figure 2:Global Next-Generation Oncology Devices and Solutions Market (by Region), $Million, 2021 and 2031 Figure 3:Global Next-Generation Oncology Devices and Solutions Market Segmentation Figure 4:Global Next-Generation Oncology Devices and Solutions Market Research Methodology Figure 5:Primary Research Figure 6:Secondary Research Figure 7:Data Triangulation Figure 8:Global Next-Generation Oncology Devices and Solutions Market Research Process Figure 9:Assumptions and Limitations Figure 10:Global Next-Generation Oncology Devices and Solutions Market, Potential Forecast Scenarios Figure 11:Global Next-Generation Oncology Devices and Solutions Market Size and Growth Potential (Realistic Scenario), $Million, 2020-2031 Figure 12:Global Next-Generation Oncology Devices and Solutions Market Size and Growth Potential (Optimistic Scenario), $Million, 2020-2031 Figure 13:Global Next-Generation Oncology Devices and Solutions Market Size and Growth Potential (Pessimistic/Conservative Scenario), $Million, 2020-2031 Figure 14:Global Next-Generation Oncology Devices and Solutions Market Key Trends, Short-Term Potential Figure 15:Global Next-Generation Oncology Devices and Solutions Market Key Trends, Long-Term Potential Next-Generation Oncology Devices and Solutions Market Figure 16:Global Next-Generation Oncology Devices and Solutions Market, Patent Analysis (by Country), January 2018-April 2022 Figure 17:Global Next-Generation Oncology Devices and Solutions Market, Patent Analysis (by Year), January 2018–April 2022 Figure 18:Key Players’ Product Offerings (by Type) Figure 19:Global Next-Generation Oncology Devices and Solutions Market, Pre-COVID-19 Phase, $Million, 2020-2031 Figure 20:Global Next-Generation Oncology Devices and Solutions Market, Impact Analysis Figure 21:Global Number of New Cases for All Cancers, 2020-2040 Figure 22:Global Next-Generation Oncology Devices and Solutions Market (by Clinical Application) Figure 23:Global Next-Generation Oncology Devices and Solutions Market Incremental Opportunity (by Clinical Application), $Million, 2021-2031 14 All rights reserved at BIS Research Inc.

  15. Figure 24:Global Next-Generation Oncology Devices and Solutions Market, Growth-Share Matrix (by Clinical Application), 2021-2031 Figure 25:Global Next-Generation Oncology Devices and Solutions Market (Lung Cancer), $Million, 2020- 2031 Figure 26:Global Next-Generation Oncology Devices and Solutions Market (Prostate Cancer), $Million, 2020-2031 Figure 27:Global Next-Generation Oncology Devices and Solutions Market (Breast Cancer), $Million, 2020- 2031 Figure 28:Global Next-Generation Oncology Devices and Solutions Market (Others), $Million, 2020-2031 Figure 29:Global Next-Generation Oncology Devices and Solutions Market (by End User) Figure 30:Global Next-Generation Oncology Devices and Solutions Market Incremental Opportunity (by End User), $Million, 2021-2031 Figure 31:Global Next-Generation Oncology Devices and Solutions Market, Growth-Share Matrix (by End User), 2021-2031 Figure 32:Global Next-Generation Oncology Devices and Solutions Market (Hospitals), $Million, 2020-2031 Figure 33:Global Next-Generation Oncology Devices and Solutions Market (Diagnostic Imaging Centers), $Million, 2020-2031 Figure 34:Global Next-Generation Oncology Devices and Solutions Market (Others), $Million, 2020-2031 Figure 35:Global Next-Generation Oncology Devices and Solutions Market (by Type) Figure 36:Global Next-Generation Oncology Devices and Solutions Market Incremental Opportunity (by Type), $Million, 2021-2031 Figure 37:Global Next-Generation Oncology Devices and Solutions Market, Growth-Share Matrix (by Type), 2021-2031 Next-Generation Oncology Devices and Solutions Market Figure 38:Global Next-Generation Oncology Devices and Solutions Market (High-Intensity Focused Ultrasound), $Million, 2020-2031 Figure 39:Global Next-Generation Oncology Devices and Solutions Market (Advanced Forms of Radiation Therapy), $Million, 2020-2031 Figure 40:Global Next-Generation Oncology Devices and Solutions Market (Others), $Million, 2020-2031 Figure 41:Global Next-Generation Oncology Devices and Solutions Market, Devices (Diagnosis), $Million, 2020-2031 Figure 42:Global Next-Generation Oncology Devices and Solutions Market, Devices (Treatment and Monitoring), $Million, 2020-2031 Figure 43:Global Next-Generation Oncology Devices and Solutions Market, Software (Diagnosis), $Million, 2020-2031 Figure 44:Global Next-Generation Oncology Devices and Solutions Market, Software (Treatment and Monitoring), $Million, 2020-2031 15 All rights reserved at BIS Research Inc.

  16. Figure 45:Global Next-Generation Oncology Devices and Solutions Market Share (by Region), 2021-2031 Figure 46:North America Next-Generation Oncology Devices and Solutions Market Incremental Opportunity (by Country), $Million, 2021-2031 Figure 47:Prevalence of Different Cancer in North America, 2010, 2015, and 2019 Figure 48:Number of New Cases for All Cancers in North America, 2020-2040 Figure 49:North America Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031 Figure 50:North America Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031 Figure 51:North America Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031 Figure 52:North America Next-Generation Oncology Devices and Solutions Market (by Type), $Million, 2020-2031 Figure 53:North America Next-Generation Oncology Devices and Solutions Market, Devices (by Technology), $Million, 2020-2031 Figure 54:North America Next-Generation Oncology Devices and Solutions Market, Devices (by Application), $Million, 2020-2031 Figure 55:North America Next-Generation Oncology Devices and Solutions Market, Software (by Application), $Million, 2020-2031 Figure 56:North America Next-Generation Oncology Devices and Solutions Market (by Country), $Million, 2021 and 2031 Figure 57:U.S. Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031 Figure 58:U.S. Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031 Next-Generation Oncology Devices and Solutions Market Figure 59:U.S. Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020- 2031 Figure 60:Canada Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031 Figure 61:Canada Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031 Figure 62:Canada Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020- 2031 Figure 63:Europe Next-Generation Oncology Devices and Solutions Market Incremental Opportunity (by Country), $Million, 2021-2031 Figure 64:Number of New Cases for All Cancers in Europe, 2020-2040 Figure 65:Europe Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031 Figure 66:Europe Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031 16 All rights reserved at BIS Research Inc.

  17. Figure 67:Europe Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020- 2031 Figure 68:Europe Next-Generation Oncology Devices and Solutions Market (by Type), $Million, 2020-2031 Figure 69:Europe Next-Generation Oncology Devices and Solutions Market, Devices (by Technology), $Million, 2020-2031 Figure 70:Europe Next-Generation Oncology Devices and Solutions Market, Devices (by Application), $Million, 2020-2031 Figure 71:Europe Next-Generation Oncology Devices and Solutions Market, Software (by Application), $Million, 2020-2031 Figure 72:Europe Next-Generation Oncology Devices and Solutions Market (by Country), $Million, 2021 and 2031 Figure 73:Germany Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031 Figure 74:Germany Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031 Figure 75:Germany Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031 Figure 76:U.K. Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031 Figure 77:U.K. Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031 Figure 78:U.K. Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020- 2031 Figure 79:France Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031 Figure 80:France Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031 Next-Generation Oncology Devices and Solutions Market Figure 81:France Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020- 2031 Figure 82:Italy Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031 Figure 83:Italy Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031 Figure 84:Italy Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020- 2031 Figure 85:Spain Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031 Figure 86:Spain Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031 Figure 87:Spain Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020- 2031 17 All rights reserved at BIS Research Inc.

  18. Figure 88:Rest-of-Europe Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031 Figure 89:Rest-of-Europe Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031 Figure 90:Rest-of-Europe Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031 Figure 91:Asia-Pacific Next-Generation Oncology Devices and Solutions Market Incremental Opportunity (by Country), $Million, 2021-2031 Figure 92:Prevalence of Different Cancer in Asia-Pacific, 2010, 2015, and 2019 Figure 93:Number of New Cases for All Cancers in Asia-Pacific, 2020-2040 Figure 94:Asia-Pacific Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031 Figure 95:Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031 Figure 96:Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031 Figure 97:Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by Type), $Million, 2020- 2031 Figure 98:Asia-Pacific Next-Generation Oncology Devices and Solutions Market, Devices (by Technology), $Million, 2020-2031 Figure 99:Asia-Pacific Next-Generation Oncology Devices and Solutions Market, Devices (by Application), $Million, 2020-2031 Figure 100:Asia-Pacific Next-Generation Oncology Devices and Solutions Market, Software (by Application), $Million, 2020-2031 Figure 101:Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by Country), $Million, 2021 and 2031 Next-Generation Oncology Devices and Solutions Market Figure 102:Japan Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031 Figure 103:Japan Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031 Figure 104:Japan Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020- 2031 Figure 105:China Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031 Figure 106:China Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031 Figure 107:China Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020- 2031 Figure 108:Australia Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031 18 All rights reserved at BIS Research Inc.

  19. Figure 109:Australia Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031 Figure 110:Australia Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031 Figure 111:India Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031 Figure 112:India Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031 Figure 113:India Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020- 2031 Figure 114:South Korea Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031 Figure 115:South Korea Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031 Figure 116:South Korea Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031 Figure 117:Rest-of-Asia-Pacific Next-Generation Oncology Devices and Solutions Market, $Million, 2020- 2031 Figure 118:Rest-of-Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031 Figure 119:Rest-of-Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031 Figure 120:Rest-of-the-World Next-Generation Oncology Devices and Solutions Market Incremental Opportunity (by Country), $Million, 2021-2031 Figure 121:Number of New Cases for All Cancers in Africa and Latin America, 2020-2040 Next-Generation Oncology Devices and Solutions Market Figure 122:Rest-of-the-World Next-Generation Oncology Devices and Solutions Market, $Million, 2020- 2031 Figure 123:Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031 Figure 124:Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031 Figure 125:Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by Type), $Million, 2020-2031 Figure 126:Rest-of-the-World Next-Generation Oncology Devices and Solutions Market, Devices (by Technology), $Million, 2020-2031 Figure 127:Rest-of-the-World Next-Generation Oncology Devices and Solutions Market, Devices (by Application), $Million, 2020-2031 Figure 128:Rest-of-the-World Next-Generation Oncology Devices and Solutions Market, Software (by Application), $Million, 2020-2031 19 All rights reserved at BIS Research Inc.

  20. Figure 129:Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by Country), $Million, 2021 and 2031 Figure 130:K.S.A. Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031 Figure 131:K.S.A. Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031 Figure 132:K.S.A. Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020- 2031 Figure 133:Brazil Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031 Figure 134:Brazil Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031 Figure 135:Brazil Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020- 2031 Figure 136:U.A.E. Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031 Figure 137:U.A.E. Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031 Figure 138:U.A.E. Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020- 2031 Figure 139:Mexico Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031 Figure 140:Mexico Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031 Figure 141:Mexico Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031 Figure 142:Rest-of-Rest-of-the-World Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031 Next-Generation Oncology Devices and Solutions Market Figure 143:Rest-of-Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million, 2020-2031 Figure 144:Rest-of-Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-2031 Figure 145:Share of Key Developments and Strategies, January 2018-April 2022 Figure 146:Regulatory and Legal Activities (by Company), January 2018-April 2022 Figure 147:Partnerships, Alliances, and Business Expansions (by Company), January 2018-April 2022 Figure 148:New Offerings (by Company), January 2018-April 2022 Figure 149:Mergers and Acquisitions (by Company), January 2018-April 2022 Figure 150:Funding Activities (by Company), January 2018-April 2022 Figure 151:Global Next-Generation Oncology Devices and Solutions Market, Company Revenue Share Analysis, $Million, 2021 20 All rights reserved at BIS Research Inc.

  21. List of Tables Table 1: Global Next-Generation Oncology Devices and Solutions Market, Quarterly Key Developments Analysis, January 2018-April 2022 Table 2: Global Next-Generation Oncology Devices and Solutions Market, Key Entry Barriers and Possible Solutions Table 3: Key Software Solutions in Oncology Table 4: Key Technologies and Products in Oncology for Diagnosis and Treatment Table 5: Key Players Offering HIFU Devices for Cancer Table 6: Key Products Based on IGRT and IMRT Technology Table 7: Key Players Offering Next-Generation Oncology Devices for Diagnosis Table 8: Key Players Offering Next-Generation Oncology Devices for Treatment and Monitoring of Cancer Table 9: Key Players Offering Next-Generation Oncology Software for Diagnosis Table 10:Key Players Offering Next-Generation Oncology Software for Treatment and Monitoring Table 11:North America Next-Generation Oncology Devices and Solutions Market Regulatory Framework Table 12:U.S. Next-Generation Oncology Devices and Solutions Market, Key Players and Product Offering Table 13:North America Next-Generation Oncology Devices and Solutions Market Dynamics Impact Analysis Table 14:Key Players in France Next-Generation Oncology Devices and Software Market Table 15:Key Players in Rest-of-Europe Next-Generation Oncology Devices and Solutions Market Table 16:Europe Next-Generation Oncology Devices and Solutions Market Dynamics Impact Analysis Table 17:Asia-Pacific Next-Generation Oncology Devices and Solutions Market Regulatory Framework Next-Generation Oncology Devices and Solutions Market Table 18:Asia-Pacific Next-Generation Oncology Devices and Solutions Market Dynamics Impact Analysis Table 19:Rest-of-the-World Next-Generation Oncology Devices and Solutions Market Regulatory Framework Table 20:Rest-of-the-World Next-Generation Oncology Devices and Solutions Market Dynamics Impact Analysis 21 All rights reserved at BIS Research Inc.

  22. BIS Research Offerings: We are on a mission to harness the potential of disruptive technologies to make businesses thrive in today’s digital age. We have a vision to be a leading and a preferred knowledge partner for corporates and institutions worldwide and assist them with market intelligence in the area of emerging technologies, advisories, and other innovative solutions. Know More Know More Know More Next-Generation Oncology Devices and Solutions Market Know More 22 All rights reserved at BIS Research Inc.

  23. Disclaimer BIS Research Inc. provides valuable market intelligence to an exclusive group of customers in response to orders. The report is licensed for the customer's internal use only and is subject to restrictions set henceforth. This document and its contents are confidential and may not be further distributed, published, or reproduced, in whole or in part, by any medium or in any form for any purpose, without the written consent of BIS Research Inc. Customer will not disclose the contents of the report, whether directly in any media or indirectly through incorporation in a database, marketing list, report or otherwise, or use or permit the use of Information to generate any statistical or other information that is or will be provided to third parties; or voluntarily produce Information in legal proceedings. Market reports are based on expectations, estimates, and projections as of the date such information is available. Any recommendation contained in this report may not be suitable for all investors or businesses. The market conclusions drawn are necessarily based upon a number of estimates and assumptions that, while considered reasonable by BIS Research Inc. as of the date of such statements, are inherently subject to market fluctuations and business, economic and competitive uncertainties and contingencies For more details regarding permission, please contact us: Email: sales@bisresearch.com Tel: +1 510 404 8135 Next-Generation Oncology Devices and Solutions Market 23 All rights reserved at BIS Research Inc.

  24. Next-Generation Oncology Devices and Solutions Market BIS RESEARCH INC. 39111 Paseo Padre PKWY, Suite 313 Fremont, CA 94538 -1686 E-mail: hello@bisresearch.com | Call Us: +1-510-404-8135 Global Delivery Center Tower B First Floor, Tapasya Corporate Heights, Greater Noida Expressway, Sector 126, Noida, U.P., 201303, India Tel: +91 120 4261540 / 4261544 24 www.bisresearch.com All rights reserved at BIS Research Inc.

More Related